GENE ONLINE|News &
Opinion
Blog

2025-04-03|

Layoffs in Biotech and Pharma: A March 2025 Snapshot by Therapeutic and Technology Focus

by Bernice Lottering
Share To
Nkarta, ElevateBio, Atea Pharmaceuticals, Lyndra Therapeutics, and Alector have all recently announced significant layoffs, with Nkarta cutting 34% of its workforce (53 employees), ElevateBio reducing 17%, Atea cutting 25%, Lyndra winding down operations after layoffs, and Alector reducing 13%, primarily due to cost-cutting measures and a focus on strategic priorities like product development and scaling operations.
In early 2025, a wave of layoffs is sweeping through the biotech and pharmaceutical industries, driven by shifting priorities, financial pressures, and strategic pivots. Companies across various therapeutic areas and technological specialties—from infectious disease vaccines to oncology and gene therapies—are resizing their workforces. Briefly, the moves by key focus areas, spotlighting the companies, their assets, … Layoffs in Biotech and Pharma: A March 2025 Snapshot by Therapeutic and Technology Focus Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.

GO Prime with only $1.49 now

LATEST
Health Insurers Adopt Wearable Data Tracking Models Similar to Automotive Telematics
2026-08-14
Biogen’s Alzheimer’s Tau Drug Splits Experts: Can Diranersen Challenge Leqembi?
2026-08-14
Definium’s Psychedelic Anxiety Drug DT120 Moves Closer to the Mainstream With a Phase 3 Win
2026-08-14
JAMA Network Open Study Links Agent Orange and Burn Pit Exposure to Veteran Health Outcomes
2026-08-14
La Mojana Earthworks Reveal Long-Term Sustainable Water Management by Pre-Hispanic Societies
2026-08-13
Grant Evaluators Divided Over Prioritizing Past Performance Versus Future Potential
2026-08-13
UC Riverside Study Finds High-Intensity Running Does Not Reduce Lifespan in Mice
2026-08-13
Scroll to Top